Hand Eczema Treatment Safety and Effectiveness Registry
Part of Skin clinical trials.
This registry collects information about how well medications work for chronic hand eczema and how safe they are over time. You'll share your health data and treatment experiences through simple online forms to help doctors better understand which treatments work best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with moderate-to-severe chronic hand eczema by a dermatologist or qualified healthcare provider
- At least 18 years old and legally able to consent to research
- Willing and able to complete health forms electronically on your phone, tablet, or computer
- Able to provide basic personal information (name, email, time zone) to create a registry account
- Not currently enrolled in or planning to join a blinded (hidden-treatment) clinical trial for hand eczema medication
- Willing to share additional personal details (address, date of birth, phone number) if required by your location
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies chronic hand eczema (and sometimes related atopic skin disease) to better understand your condition and what may be going on in the skin. You may be asked to follow a study plan for a set period and avoid certain treatments just before joining.
This registry tracks the safety and effectiveness of medications used for moderate to severe atopic dermatitis (eczema) in adolescents aged 10 to 15. It helps doctors understand how well these treatments work and what side effects might occur over time.
This study is a real-world registry that collects information from adults with atopic dermatitis (eczema) to track how newly started treatments work and how safe they are over time. It may help researchers and doctors better understand medication effects in everyday care.
This study examines the immune cells and proteins in chronic hand eczema samples. By comparing skin from affected and healthy areas, researchers hope to find new targets for treatment.
This study tracks how well delgocitinib cream works and how safe it is for people with chronic hand eczema in everyday use. Researchers collect information from your doctor visits to understand if this treatment helps manage your hand eczema symptoms.
This registry collects information about people with atopic eczema who begin light therapy (phototherapy) or medicine that changes the immune system. It may help doctors better understand how these treatments work in everyday care in the Netherlands.
Hear when a new Chronic Hand Eczema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.